Dysregulated expression of MIC-1/PDF in human prostate tumor cells

被引:68
作者
Karan, D
Chen, SJ
Johansson, SL
Singh, AP
Paralkar, VM
Lin, MF
Batra, SK
机构
[1] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[3] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Univ Nebraska, Med Ctr, Dept Surg, Urol Sect, Omaha, NE USA
关键词
LNCaP cell model; MIC-1/PDF; prostate cancer; immunohistochemistry;
D O I
10.1016/S0006-291X(03)00823-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As a part of the study to identify genes associated with hormone-refractory stage of human prostate cancer, we have recently identified several genetic and epigenetic changes that seem to be associated with the progression of androgen-sensitive to androgen-independent prostate tumor cells. In the present study, we report a novel gene, macrophage inhibitory cytokine-1 (MIC-1) also known as prostate derived factor (PDT), that was highly expressed in androgen-independent LNCaP-C81 cells and its metastatic variant LNCaP-Ln3 compared to androgen-sensitive LNCaP-C33 cells. The MIC-1/PDF expression was dysregulated (very low to non-detectable) in the androgen-independent PC3 and DU145 cells. Interestingly, serum factors demonstrated a differential regulation of MIC-1/PDF in the androgen-sensitive and the androgen-independent cells of LNCaP cells. Immunohistochemical analysis on 15 prostatic adenocarcinomas showed a weak staining in the benign prostatic glandular area (intensity score 2.38 +/- 0.25; n = 13), while the immunoreactivity was significantly stronger (p < 0.05) in areas of adenocarcinoma (score 7.33 +/- 0.88; n = 15). Altogether, these data suggest that the serum factors (including androgens and cytokines) might contribute to the regulation of the MIC-1/PDF gene that seems to be associated with the progression of prostate cancer. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 28 条
  • [1] Barrack ER, 1997, PROSTATE, V31, P61
  • [2] BATRA SK, 1991, J CELL SCI, V100, P841
  • [3] MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily
    Bootcov, MR
    Bauskin, AR
    Valenzuela, SM
    Moore, AG
    Bansal, M
    He, XY
    Zhang, HP
    Donnellan, M
    Mahler, S
    Pryor, K
    Walsh, BJ
    Nicholson, RC
    Fairlie, WD
    Por, SB
    Robbins, JM
    Breit, SN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11514 - 11519
  • [4] Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
    Brown, DA
    Breit, SN
    Buring, J
    Fairlie, WD
    Bauskin, AR
    Liu, T
    Ridker, PM
    [J]. LANCET, 2002, 359 (9324) : 2159 - 2163
  • [5] Buckhaults P, 2001, CANCER RES, V61, P6996
  • [6] Androgen receptors in prostate cancer
    Culig, Z
    Klocker, H
    Bartsch, G
    Hobisch, A
    [J]. ENDOCRINE-RELATED CANCER, 2002, 9 (03) : 155 - 170
  • [7] THE ENDOCRINOLOGY AND DEVELOPMENTAL BIOLOGY OF THE PROSTATE
    CUNHA, GR
    DONJACOUR, AA
    COOKE, PS
    MEE, S
    BIGSBY, RM
    HIGGINS, SJ
    SUGIMURA, Y
    [J]. ENDOCRINE REVIEWS, 1987, 8 (03) : 338 - 362
  • [8] MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation
    Fairlie, WD
    Moore, AG
    Bauskin, AR
    Russell, PK
    Zhang, HP
    Breit, SN
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (01) : 2 - 5
  • [9] The development of androgen-independent prostate cancer
    Feldman, BJ
    Feldman, D
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 34 - 45
  • [10] FLEMING ID, 1997, AJCC CANC STAINING M, P1